Is the association between cigarette smoking and Parkinson disease causal? A Mendelian Randomization study.
Objective: To determine whether the association between cigarette smoking and Parkinson disease (PD) is causal using 2-sample Mendelian randomization (MR) and to examine the potential…Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up
Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…Parkinson’s disease and Post-COVID-19 syndrome
Objective: To report the prevalence of Post-Corona Virus Disease 2019 (COVID-19) syndrome in a case series of Parkinson’s disease (PD) patients. Background: Implications of COVID-19…WATCH-PD: Wearable Assessments in the Clinic and Home in Parkinson’s Disease: Baseline Analyses
Objective: To provide a profile of early Parkinson’s disease (PD) using clinical and digital measures and determine whether digital measures can differentiate PD and controls…Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease
Objective: To investigate satisfaction with daily remote monitoring with a digital health technology tool (DHTT) in individuals with early Parkinson’s disease (PD) and the relationship…Climb up! Head up! Effectiveness and feasibility of sport climbing in Parkinson’s disease
Objective: The current study examines the effectiveness and feasibility of sport climbing in PD patients in a single-centre, randomised controlled, semi-blind trial. Background: Physical activity…Feasibility of dance therapy through synchrony videoconference in Parkinson’s disease and elderly people.
Objective: To investigate the safety and effectiveness of online dance classes (in live) in a group of people with and without Parkinson's Disease. Background: Dance…CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform
Objective: Development of a treatment for nocturnal and early morning OFF symptomology in Parkinson’s disease. Background: Levodopa Parkinson’s disease (PD) treatment is limited by its…Global access to Parkinson’s disease treatment
Objective: To examine the availability of PD treatment by country, and analyse differences by national income as defined by the World Bank (high income countries…Opicapone in Parkinson’s disease patients with early/simple motor fluctuations: real-world Spanish data
Objective: To evaluate the efficacy and tolerability of opicapone in patients in Parkinson’s disease (PD) patients with early/simple motor fluctuations (E/S-MF) in the Spanish clinical…
- « Previous Page
- 1
- …
- 376
- 377
- 378
- 379
- 380
- …
- 436
- Next Page »